Stay updated with breaking news from Equal Life. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
European Commission decision on marketing authorization anticipated first quarter of 2022 Oxbryta would be the first oral treatment available in Europe to directly inhibit sickle hemoglobin (HbS) polymerization
Investegate announcements from Global Blood Therapeutics, Inc, GBT’s Oxbryta® (voxelotor) Receives Positive CHMP Opinion for the Treatment of Hemolytic Anemia in Patients with Sickle Cell Disease Aged 12 Years and Older
St. Gallen, Switzerland: Iron Deficiency Day unites a strong international coalition dedicated to raising international awareness on the serious health - Report on The Eastern Herald
Iron Deficiency Day unites a strong international coalition dedicated to raising international awareness on the serious health impact of iron deficiency and iron deficiency anemia1 Patient
Commentary: The House Republican Leadership team today called on the Governor to convene an immediate Special Session of the New Mexico Legislature to